← USPTO Patent Grants

Heparin and N-acetylcysteine for the treatment of lung injury

Grant US12576103B2 Kind: B2 Mar 17, 2026

Assignee

Atossa Therapeutics, Inc.

Inventors

Steven C. Quay

Abstract

Disclosed herein are compositions and methods for treatment or prevention of a respiratory viral infection. A composition of the present disclosure comprises one or more of heparin, or N-acetylcysteine. A composition for treatment or prevention of a respiratory viral infection may be administered by inhalation in intervals. Administration of a composition may treat or prevent a viral infection.

CPC Classifications

A61K 31/727 A61K 9/0078 A61K 31/198 A61K 45/06 A61K 47/183

Filing Date

2021-03-19

Application No.

17802711

Claims

16